Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix Dosing Regimens in Prostate Cancer (FE 200486 CS12)
DRKS00000024Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Sep 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started Sep 2008; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on DRKS00000024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000024.